Title:
PROPHYLAXIS AGAINST CANCER METASTASIS
Document Type and Number:
WIPO Patent Application WO/2011/014863
Kind Code:
A3
Abstract:
This document provides prophylactic methods for reducing cancer metastasis by targeting LCN2, MMP9, and CXCR4.
Inventors:
ALT ECKHARD U (US)
ARLINGHAUS RALPH B (US)
COLEMAN MICHAEL E (US)
ARLINGHAUS RALPH B (US)
COLEMAN MICHAEL E (US)
Application Number:
PCT/US2010/044070
Publication Date:
June 23, 2011
Filing Date:
August 02, 2010
Export Citation:
Assignee:
ALT ECKHARD U (US)
ARLINGHAUS RALPH B (US)
COLEMAN MICHAEL E (US)
ARLINGHAUS RALPH B (US)
COLEMAN MICHAEL E (US)
International Classes:
A61P35/00; A61K39/395
Foreign References:
| US20050002939A1 | 2005-01-06 | |||
| US20030109690A1 | 2003-06-12 | |||
| US20040132642A1 | 2004-07-08 | |||
| US20030195461A1 | 2003-10-16 |
Other References:
HAN SHI ET AL.: "Lipocalin 2 promotes lung metastasis of murine breast cancer cells.", JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, vol. 27, 2008, pages 83, XP021052958, Retrieved from the Internet DOI: doi:10.1186/1756-9966-27-83
ANJA MUELLER ET AL.: "Involvement of chemokine receptors in breast cancer metastasis.", NATURE, vol. 410, no. 6824, 2001, pages 50 - 56, XP002292390, DOI: doi:10.1038/35065016
ANJA MUELLER ET AL.: "Involvement of chemokine receptors in breast cancer metastasis.", NATURE, vol. 410, no. 6824, 2001, pages 50 - 56, XP002292390, DOI: doi:10.1038/35065016
Attorney, Agent or Firm:
MCCORMICK GRAHAM, Monica et al. (P.O. Box 1022Minneapolis, Minnesota, US)
Download PDF: